Fig. 1 · Structure
Documents & Downloads
Tofacitinib metabolite-1
Cat. No.
A70163
CAS
1640971-51-2
Drug Metabolite
Tofacitinib metabolite-1 is a metabolite derived from Tofacitinib, a selective inhibitor of Janus kinase (JAK) enzymes. This compound plays a critical role in pharmacokinetic and metabolic studies of Tofacitinib, facilitating the understanding of its bioavailability, metabolism, and overall therapeutic efficacy. Researchers can utilize Tofacitinib metabolite-1 to investigate its biological activity and potential impacts on various signaling pathways involved in inflammatory processes.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1640971-51-2 |
| Applications | Drug Metabolite |
| Formula | C16H20N6O2 |
| Molecular Weight | 328.37 |
| SMILES | CN([C@H]([C@@H](CC1)C)CN1C(CC#N)=O)C2=C(CC3=O)C(N3)=NC=N2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.